Filing Details
- Accession Number:
- 0001315406-11-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-18 12:41:51
- Reporting Period:
- 2011-11-16
- Filing Date:
- 2011-11-18
- Accepted Time:
- 2011-11-18 12:41:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 12208 | Bio Rad Laboratories Inc | BIO, BIOB | Laboratory Analytical Instruments (3826) | 941381833 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1246406 | Bradford Crutchfield | C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Acquisiton | 2011-11-16 | 4,000 | $28.61 | 9,811 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Disposition | 2011-11-16 | 4,000 | $97.93 | 5,811 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-11-16 | 4,000 | $0.00 | 4,000 | $28.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-02-06 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.84 to $98.40, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vested in five equal annual installments beginning on February 6, 2003.
Billionaire Hedge Funds
